RBX1P2

Across TCGA pan-cancer cohorts, RBX1P2 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RBX1P2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RBX1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBX1P2 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LUAD show a favorable association.

COAD, PAAD, and KIRC are the cancer types where RBX1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Quartile	All	0.682	0.820	<.001	110	view →
PAAD	OS	Tertile	All	0.637	0.367	<.001	65	view →
KIRC	DFS	Median	II,III,IV	0.420	0.617	.001	61	view →
LIHC	OS	Quartile	II,III,IV	0.472	0.842	<.001	45	view →
LUAD	OS	Tertile	All	0.868	0.672	<.001	19	view →
LGG	DFS	Tertile	All	0.772	0.867	<.001	19	view →
HNSC	OS	Tertile	III,IV	0.482	0.304	.021	18	view →
READ	OS	Tertile	III,IV	0.842	0.273	.006	14	view →
SKCM	OS	Tertile	All	0.422	0.247	.003	11	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	10	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.303	.013	9	view →
OV	OS	Tertile	IV	0.451	0.778	.008	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RBX1P2–COAD (DFS)

Open the COAD breakdown →